Myobloc FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 23, 2020.
FDA Approved: Yes (First approved December 8, 2000)
Brand name: Myobloc
Generic name: rimabotulinumtoxinB
Dosage form: Injection
Company: Supernus Pharmaceuticals, Inc.
Treatment for: Cervical Dystonia, Sialorrhea
Myobloc (rimabotulinumtoxinB) is an acetylcholine release inhibitor indicated for the treatment of cervical dystonia and chronic sialorrhea.
Development timeline for Myobloc
| Date | Article |
|---|---|
| Aug 26, 2019 | Approval FDA Approves Myobloc (rimabotulinumtoxinB) Injection for Chronic Sialorrhea |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.